ConductScience.org, home

Gene · 2621

NIH grants2,018

NIH grants whose papers are about the gene, through NIH's grant-paper links.

901 to 920 of 2,018

Download this page as JSON
GrantTitleGAS6 papersNewest fiscal year
P30GM118247Mechanisms of Liver Injury and Diseases12020
P50CA058236SPORE in Prostate Cancer12020
P50CA098258MD Anderson Gynecologic SPORE for Uterine Cancers12020
P50CA196510Washington University SPORE in Pancreatic Cancer12020
R00CA207866Investigating the role of the extracellular matrix in metastasis and chemo-resistance12020
R01AG051601Regulation of lifespan12020
R01AI011219Structure and Function of Icosahedral Viruses12020
R01AI064099Mechanism of cell-associated HIV-1 transmission12020
R01AI121183Mechanisms regulating fetal membrane and neutrophil responses to polymicrobial infection12020
R01AI121250IL-33 Blockade as a Novel Therapeutic for T-cell Mediated Hypercytokinemia Syndromes12020
R01AI121405Epigenetic modulation of T cell tolerance in Multiple Sclerosis autoimmunity12020
R01AI123284Non-Canonical Cross-presentation in Dendritic Cells Upon TAP Blockade12020
R01AI126909Pathogenesis of HRPII in Cerebral Malaria12020
R01AI127658Novel vita-vaccine formula combines safety of dead and efficacy of live vaccines12020
R01AR069681Roles of HDAC3 in Epidermal Langerhans Cell Ontogeny and Function12020
R01CA064786Definition of the Microenvironment in Breast Cancer12020
R01CA072597Oncogenic Events in Thyroid Neoplasia12020
R01CA187392Tumor-associated neutrophils in human lung cancer12020
R01CA193583Estrogen Signaling in a Mouse Model for Lymphangioleiomyomatosis12020
R01CA193935The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer.12020

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/2621/grants?page=46